Looking to sell Ossium Health stock or options?
Ossium Health develops stem cell-based therapies aimed at enhancing human health, vitality, and longevity through bioengineering. These therapies target the cure of leukemia and other blood disorders, enhance organ transplantation outcomes, treat radiation poisoning, and facilitate tissue repair. By doing so, Ossium Health empowers healthcare professionals to significantly boost the well-being, vitality, and lifespan of individuals.
Elevate Ventures, First Round Capital, Asahi Kasei, Junchao Shangguan, Alumni Ventures, Manta Ray Ventures, Mike Kruzeniski, Gaingels, B Capital Group, Hemisphere Ventures, Mount Pleasant Ventures, National Institute of General Medical Sciences, Nikhil Agarwal, and Blood Institute, CPMG, National Heart, U.S. Department of Health and Human Services, Alex Felix, National Institute for Allergy and Infectious Disease, Maynd Jolly, General Catalyst, XYZ Venture Capital, Village Global, Lung, Wormhole Capital.
Ossium Health is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Ossium Health stock. Depending on Ossium Health’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Ossium Health stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Ossium Health stock in two ways. First, Ossium Health employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Ossium Health stock. Note that all transactions in Ossium Health shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Ossium Health stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Ossium Health stock. Typically, shares of private companies like Ossium Health are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Jul 2023, Ossium Health is reported to have closed an equity financing in which the investors valued the company at $309M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Ossium Health shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Ossium Health is not currently publicly traded, it does not have a ticker symbol.
Ossium Health has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Ossium Health is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Ossium Health shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.